PT2563374E - Composições de polietileno glicol para o controlo da reincidência de herpes labial, herpes genital, e herpes zóster - Google Patents

Composições de polietileno glicol para o controlo da reincidência de herpes labial, herpes genital, e herpes zóster Download PDF

Info

Publication number
PT2563374E
PT2563374E PT117549196T PT11754919T PT2563374E PT 2563374 E PT2563374 E PT 2563374E PT 117549196 T PT117549196 T PT 117549196T PT 11754919 T PT11754919 T PT 11754919T PT 2563374 E PT2563374 E PT 2563374E
Authority
PT
Portugal
Prior art keywords
peg
polyethylene glycol
topical administration
weight
recurrence
Prior art date
Application number
PT117549196T
Other languages
English (en)
Portuguese (pt)
Inventor
Peter Vitins
Marcel Langenauer
Paul Martin Scherer
Original Assignee
Devirex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Devirex Ag filed Critical Devirex Ag
Publication of PT2563374E publication Critical patent/PT2563374E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT117549196T 2010-07-08 2011-07-08 Composições de polietileno glicol para o controlo da reincidência de herpes labial, herpes genital, e herpes zóster PT2563374E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36232910P 2010-07-08 2010-07-08

Publications (1)

Publication Number Publication Date
PT2563374E true PT2563374E (pt) 2014-01-23

Family

ID=44588123

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117549196T PT2563374E (pt) 2010-07-08 2011-07-08 Composições de polietileno glicol para o controlo da reincidência de herpes labial, herpes genital, e herpes zóster

Country Status (20)

Country Link
US (2) US9814743B2 (OSRAM)
EP (1) EP2563374B1 (OSRAM)
JP (1) JP5858994B2 (OSRAM)
KR (1) KR101881175B1 (OSRAM)
CN (1) CN103079574B (OSRAM)
AU (1) AU2011275458B2 (OSRAM)
CA (1) CA2803228C (OSRAM)
DK (1) DK2563374T3 (OSRAM)
ES (1) ES2442928T3 (OSRAM)
HR (1) HRP20140135T1 (OSRAM)
IL (1) IL223582A (OSRAM)
MX (1) MX2012014783A (OSRAM)
PL (1) PL2563374T3 (OSRAM)
PT (1) PT2563374E (OSRAM)
RS (1) RS53162B (OSRAM)
RU (1) RU2643763C2 (OSRAM)
SG (1) SG186937A1 (OSRAM)
SI (1) SI2563374T1 (OSRAM)
WO (1) WO2012004669A1 (OSRAM)
ZA (1) ZA201300177B (OSRAM)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
WO2014130432A1 (en) 2013-02-19 2014-08-28 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for improving appearance and formation of scar tissue
ES2538335T3 (es) * 2013-05-14 2015-06-19 Najöpharm Gmbh I.G. Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
UY37497A (es) * 2016-11-28 2018-06-29 Aicuris Anti Infective Cures Gmbh Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida
EP3962924A1 (en) 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
WO2021233571A1 (de) * 2020-04-30 2021-11-25 Ninoderm Ug (Haftungsbeschränkt) Behandlungsmittel zur antiviralen therapie, applikator und verfahren zur herstellung eines behandlungsmittels

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4603122A (en) * 1979-08-17 1986-07-29 Blough Herbert A Antiviral agent against herpes virus infections
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
EP0087161A3 (en) 1982-02-24 1984-04-04 Key Pharmaceuticals, Inc. Isopropylmyristate 4-alkyl-2,6-(bis-tert-butyl)-phenol medicament
US5232700A (en) 1990-11-14 1993-08-03 The Administrators Of The Tulane Educational Fund Methods of prophylaxis and treatment of herpes simplex lesions utilizing piracetam as the active ingredient
NL9500216A (nl) 1995-02-06 1996-09-02 Bio Pharma Sciences Bv Farmaceutische samenstelling voor de behandeling van herpes.
US6045823A (en) * 1996-09-19 2000-04-04 Dragoco Gerberding & Co. Ag Process for producing solid anhydrous composition, and pharmaceutical and cosmetic products comprising same
GB9902227D0 (en) * 1999-02-01 1999-03-24 Cipla Limited Pharmaceutical composition for topical administration
US8030260B2 (en) * 2005-03-25 2011-10-04 Chemsil Silicones, Inc Pre-shave compositions and methods of using same
DE202005007363U1 (de) 2005-05-04 2005-07-14 Anton Hübner GmbH & Co. KG Gegen Herpesbläschen verwendbare Kieselsäurezusammensetzungen
EP2121027A2 (en) 2007-01-17 2009-11-25 Devirex AG Cyclodextrin formulations
RS53162B (sr) 2010-07-08 2014-06-30 Devirex Ag Polietilen glikolni preparati u kontroli relapsa herpes labialis-a, herpes genitalis-a i herpes zoster-a
WO2013102885A1 (en) 2012-01-06 2013-07-11 Devirex Ag Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster

Also Published As

Publication number Publication date
CA2803228A1 (en) 2012-01-12
ZA201300177B (en) 2014-03-26
HRP20140135T1 (hr) 2014-03-28
US20130090389A1 (en) 2013-04-11
JP5858994B2 (ja) 2016-02-10
AU2011275458B2 (en) 2014-11-27
MX2012014783A (es) 2013-04-03
AU2011275458A1 (en) 2013-02-28
RS53162B (sr) 2014-06-30
RU2013100383A (ru) 2014-08-20
WO2012004669A1 (en) 2012-01-12
RU2643763C2 (ru) 2018-02-05
EP2563374A1 (en) 2013-03-06
HK1180969A1 (en) 2013-11-01
IL223582A (en) 2017-12-31
DK2563374T3 (da) 2014-01-20
EP2563374B1 (en) 2013-11-13
CN103079574B (zh) 2017-04-12
PL2563374T3 (pl) 2014-04-30
JP2013530208A (ja) 2013-07-25
CN103079574A (zh) 2013-05-01
SI2563374T1 (sl) 2014-01-31
CA2803228C (en) 2019-03-12
KR101881175B1 (ko) 2018-07-23
US9814743B2 (en) 2017-11-14
ES2442928T3 (es) 2014-02-14
SG186937A1 (en) 2013-02-28
US20180055875A1 (en) 2018-03-01
KR20130142992A (ko) 2013-12-30

Similar Documents

Publication Publication Date Title
PT2563374E (pt) Composições de polietileno glicol para o controlo da reincidência de herpes labial, herpes genital, e herpes zóster
US10894069B2 (en) Topical antiviral formulations and methods of using the same
KR20090111328A (ko) 사이클로덱스트린 제형
JP4411414B2 (ja) 糖尿病性神経障害の治療に対する組成物及びその方法
JP5685315B2 (ja) ニコチン酸アデニンディヌクレオチドリン酸又はその誘導体を含む薬学又は化粧料組成物
US10500168B2 (en) Use of licochalcone a for treatment of rosacea
US9144612B2 (en) Dermatological compositions containing an association of peroxide lipids and zinc, and uses thereof in particular in the treatment of labial and/or genital herpes
WO2013102885A1 (en) Hygroscopic compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
AU2017297300A1 (en) The use of homosalate and octyl salicylate to treat multiple sclerosis
NL9020008A (nl) Niet-inspuitbare anti-kankersamenstelling, die in staat is de vorming van ontsteking als gevolg van een 5-fluoruracil type verbinding te remmen en een werkwijze voor het behandelen van kanker.
CN1744874A (zh) 预防性治疗单纯性疱疹的组合物
HK1180969B (en) Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
KR20040065979A (ko) 황산 글루코사민과 비타민 비12를 활성성분으로 함유하는퇴행성 관절염 치료용 조성물
JP2023538475A (ja) 神経向性ウイルスによる感染を治療するための薬学的組成物
EP1427400A2 (en) Triclosan dosage form
Agent Docosanol Cream, 10%
ZA200401841B (en) Triclosan dosage form.